Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab emtansine in HER2-positive metastatic breast cancer
NCT00679211Phase 2Completed
- Sponsor
- Genentech
- Start
- Aug 2008
- Primary completion
- Sep 2009
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
01
Overview
A Phase 2 trial of trastuzumab emtansine in breast cancer, sponsored by Genentech. Started Aug 2008; status: completed.
02
Drugs
trastuzumab emtansine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00679211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679211.